BLFS FY 2022 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

FY 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$76M-36.0% YoY

Gross Profit

$47M61.5% margin

Operating Income

-$6M-7.8% margin

Net Income

-$140M-183.4% margin

EPS (Diluted)

$-3.29

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$19M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$450M

Total Liabilities

$86M

Stockholders' Equity

$364M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$119M	-36.0%
Gross Profit	$47M	$29M	+62.6%
Operating Income	-$6M	-$35M	+83.2%
Net Income	-$140M	-$9M	-1469.4%